{
    "nct_id": "NCT04516213",
    "official_title": "An Open-label, Single-arm Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years.",
    "inclusion_criteria": "* Provision of signed and dated informed consent from subject and/or subject's parents or legally authorized representatives (LAR).\n* Male or female, 12 to 48 months of age, inclusive.\n* Subjects requiring enteral feeding for > 7 days (in hospital, long-term care facility or at home).\n* Subjects receiving enteral tube-feeding (nasogastric feeding tube or percutaneous endoscopic gastrostomy [PEG] tube) to provide 90% or more of their nutritional needs at the time of study entry.\n* Subject is clinically stable (i.e. absence of any significant gastrointestinal symptoms during the past 7 days), in the opinion of the investigator.\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 4 Years",
    "exclusion_criteria": "* Subjects receiving partial or total parenteral nutrition (e.g. for short bowel syndrome and other causes of intestinal failure).\n* Subjects with ongoing or intermittent significant gastrointestinal symptoms during the 7 days before enrollment.\n* Oncology patients recovering from chemotherapy or radiotherapy for hematological malignancies or solid tumors (last treatment within 3 months of enrollment).\n* Congenital immunodeficiency syndromes (SCID etc).\n* Cystic fibrosis and other causes of fat malabsorption (lymphatic malformations/lymphangiectasis).\n* Subjects with any clinically significant condition (e.g. severe malnutrition, congenital heart disease, etc) that, in the investigator's opinion, would preclude inclusion in the study.\n* Subjects at risk for poor compliance to the study protocol in the investigator's opinion.\n* Currently participating in another conflicting trial or participated in an investigational trial within 30 days of enrollment.\n* Known hypersensitivity to PHGG or to any other ingredients in the investigational product.",
    "miscellaneous_criteria": ""
}